COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis

Background: Patients with rheumatic diseases (RDs) like DM are known to be vulnerable towards various types of infections due to aggressive disease activity mandating high dose immunosuppressive therapy. The severity of COVID-19 in RDs is limited in literature due to the heterogeneous nature of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakhchanian, Haig, Khan, Hiba, Raiker, Rahul, Ahmed, Sakir, Kavadichanda, Chengappa, Abbasi, Maryam, Kardeş, Sinan, Agarwal, Vikas, Aggarwal, Rohit, Gupta, Latika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142211/
https://www.ncbi.nlm.nih.gov/pubmed/35750526
http://dx.doi.org/10.1016/j.semarthrit.2022.152034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142211/
https://www.ncbi.nlm.nih.gov/pubmed/35750526
http://dx.doi.org/10.1016/j.semarthrit.2022.152034

Ejemplares similares